Dopamine, Central

Encyclopedia of Stress

Volumn , Issue , 2007, Pages 852-859

  Stanwood, G D ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 44649161312     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012373947-6.00130-6     Document Type: Chapter

References (14)

1. Abercrombie E.D., Keefe K.A., DiFrischia D., Zigmond M. Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens and medial frontal cortex. Journal of Neurochemistry 1989, 52:1655-1658.
2. Deutch A.Y., Roth R.H. Neurotransmitters. Fundamental neuroscience 1999, 193-234. Academic Press, San Diego, CA. M.J. Zigmond, F.E. Bloom, S.C. Landis, J.L. Roberts, L.R. Squire (Eds.).
3. Finlay J.M., Zigmond M.J. The effects of stress on central dopaminergic neurons: possible clinical implications. Neurochemical Research 1997, 22:1387-1394.
4. Goldman-Rakic P.S., Muly E.C., Williams G.V. D(1) receptors in prefrontal cells and circuits. Brain Research Reviews 2000, 31:295-301.
5. Horger B.A., Roth R.H. The role of mesoprefrontal dopamine neurons in stress. Critical Reviews in Neurobiology 1996, 10:395-418.
6. Lucas L.R., Celen Z., Tamashiro K.L., et al. Repeated exposure to social stress has long-term effects on indirect markers of dopaminergic activity in brain regions associated with motivated behavior. Neuroscience 2004, 124:449-457.
7. Moghaddam B., Jackson M. Effect of stress on prefrontal cortex function. Neurotoxicological Research 2004, 6:73-78.
8. Pezze M.A., Feldon J. Mesolimbic dopaminergic pathways in fear conditioning. Progress in Neurobiology 2004, 74:301-320.
9. Piazza P.V., LeMoal M. The role of stress in drug self-administration. Trends in Pharmacological Sciences 1998, 19:67-74.
10. 11C] raclopride. Journal of Neuroscience 2004, 24:2825-2831.
11. Stanwood G.D., Levitt P. Drug exposure early in life: functional repercussions of changing neuropharmacology during sensitive periods of brain development. Current Opinion in Pharmacology 2004, 4:65-71.
12. Svenningsson P., Nishi A., Fisone G., Girault J.A., Nairn A.C., Greengard P. DARPP-32: an integrator of neurotransmission. Annual Review of Pharmacology and Toxicology 2004, 44:269-296.
13. Teicher M.H., Andersen S.L., Polcari A., Anderson C.M., Navalta C.P., Kim D.M. The neurobiological consequences of early stress and childhood maltreatment. Neuroscience and Biobehavioral Reviews 2003, 27:33-44.
14. Wood P.B. Stress and dopamine: implications for the pathophysiology of chronic widespread pain. Medical Hypotheses 2004, 62:420-424.